{{Rsnum
|rsid=711355
|Chromosome=15
|position=29901265
|Orientation=minus
|GMAF=0.4031
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=TJP1
|Gene_s=TJP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 52.2 | 32.7
| HCB | 38.7 | 45.3 | 16.1
| JPT | 17.9 | 42.9 | 39.3
| YRI | 4.8 | 44.2 | 51.0
| ASW | 5.3 | 47.4 | 47.4
| CHB | 38.7 | 45.3 | 16.1
| CHD | 31.2 | 56.9 | 11.9
| GIH | 3.0 | 40.6 | 56.4
| LWK | 6.4 | 33.6 | 60.0
| MEX | 24.1 | 44.8 | 31.0
| MKK | 3.2 | 25.6 | 71.2
| TSI | 8.8 | 53.9 | 37.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23241943
  |Trait=Response to antipsychotic treatment
  |Title=Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
  |RiskAllele=T
  |Pval=2E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}